Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (127)

1

Therapeutic potential of isatuximab in the treatment of multiple myeloma : Evidence to date

enthalten in: Seminars in oncology | 2020

von Richter, J. | Sanchez, L. | Thibaud, S.

2

An updated review of microsatellite instability in the era of next-generation sequencing and precision medicine

enthalten in: Seminars in oncology | 2019

von Yamamoto, H. | Imai, K.

3

Cancer immunotherapy-associated hypophysitis

enthalten in: Seminars in oncology | 2018

von Solinas, C. | Porcu, M. | De Silva, P. | +6

4

Nimotuzumab : beyond the EGFR signaling cascade inhibition

enthalten in: Seminars in oncology | 2018

von Mazorra, Z. | Chao, L. | Lavastida, A. | +4

5

Nivolumab and pembrolizumab : Monoclonal antibodies against programmed cell death-1 (PD-1) that are interchangeable

enthalten in: Seminars in oncology | 2017

von Prasad, V. | Kaestner, V.

6

A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab

enthalten in: Seminars in oncology | 2017

von Fessas, P. | Lee, H. | Ikemizu, S. | +1

7

Angiogenesis inhibition in the second-line treatment of metastatic colorectal cancer : A systematic review and pooled analysis

enthalten in: Seminars in oncology | 2017

von Chebib, R. | Verlingue, L. | Cozic, N. | +5

CommentIn: Semin Oncol. 2017 Apr;44(2):129-131. - PMID 28923210

8

PD-L1 inhibition with MPDL3280A for solid tumors

enthalten in: Seminars in oncology | 2015

von Cha, E. | Wallin, J. | Kowanetz, M.

9

The next generation of antibody drug conjugates

enthalten in: Seminars in oncology | 2014

von Mack, F. | Ritchie, M. | Sapra, P.

10

Cancer survivorship : cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management

enthalten in: Seminars in oncology | 2013

von Steingart, R. | Yadav, N. | Manrique, C. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]